DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» EPOCH (chemotherapy)
EPOCH (chemotherapy)
Primary Effusion Lymphoma Without an Effusion: a Rare Case of Solid Extracavitary Variant of Primary Effusion Lymphoma in an HIV-Positive Patient
BC Cancer Protocol Summary for Treatment of Lymphoma with Dose- Adjusted Etoposide, Doxorubicin, Vincristine, Cyclophosphamide
Advances in Llm
Extracavitary/Solid Variant of Primary Effusion Lymphoma Yoonjung Kim, Mda,1, Vasiliki Leventaki, Mda, Feriyl Bhaijee, Mbchbb, ⁎ Courtney C
Dose-Adjusted Epoch and Rituximab for the Treatment of Double
HIV-Triggered Lymphoma
Specific Chemotherapeutic Agents
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Myeloid Growth Factors
Granulocyte Colony Stimulating Factor Enhances Reward Learning Through Potentiation of Mesolimbic Dopamine System Function
1 Abbreviated Title: Siplizumab/EPOCH-R in T/NK NHL NCI Protocol #: 09C0065 H Version Date: 11/21/2018 NCT Number: NCT01445535 P
The Role of Glucocorticoids in the Treatment of Non-Hodgkin Lymphoma
DA-EPOCH-R IMPOR TANT: INDICATION EXTRA VASATI High Grade Lymphoma
Dose Adjusted R-EPOCH Information for Patients and Caregivers
CYCLOPHOSPHAMIDE: Class: Antineoplastic Agent, Alkylating
Comparison of Pegfilgrastim and Filgrastim for the Primary
DA (Dose Adjusted) R EPOCH
AMC-034: Randomized Phase II Trial Of
Doxorubicin (Conventional): Drug Information
Top View
Walking the Bridge Between Idea and Cure—Seventeenth Bruce F. Cain Memorial Award Lecture1
NCCP Chemotherapy Regimen
Primary Effusion Lymphoma: a Clinicopathological Study of 70 Cases
R-Split-EPOCH Plus High Dose Methotrexate in Untreated Diffuse
Bortezomib Plus EPOCH Is Effective As Frontline Treatment in Patients with Plasmablastic Lymphoma
Dose Adjusted Epoch Protocol
Antitumor Drugs and Their Targets
Gazyva (Obinutuzumab)
Hematology; Receiving DA-EPOCH at Home by CADD Pump
Mogamulizumab Plus EPOCH Therapy for Patients with Newly
DA-EPOCH Regimen
Chemotherapy Protocol LYMPHOMA REPOCH
Efficacy of Central Nervous System Prophylaxis with Stand-Alone
DA-EPOCH-R Improves the Outcome Over That of R-CHOP Regimen For
Repoch - Cyclophosphamide-Doxorubicin-Etoposide-Prednisolone- Rituximab-Vincristine
Model Protocol.New Version